New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer by Weise AM, Gadgeel S

Get full text

Review: Adjuvant therapy for resected non-small cell lung cancer by Antoinette J. Wozniak, Shirish M. Gadgeel

Get full text

Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. by Ma'in Y Maitah, Shadan Ali, Aamir Ahmad, Shirish Gadgeel, Fazlul H Sarkar

Get full text

Phase I study of OSI-906, dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) in combination with erlotinib (E) in patients w... by Macaulay, V, Middleton, MR, Eckhardt, S, Juergens, R, Stephens, A, Poondru, S, McCarthy, S, Gadgeel, S

Erlotinib resistance in Lung Cancer: Current Progress and Future Perspectives by Joy eTang, Rasha eSalama, Shirish M Gadgeel, Fazlul H Sarkar, Aamir eAhmad

Get full text

Cancer is chronic but antimicrobial stewardship is iconic: A retrospective cohort of optimal antibiotic use in ambulatory oncology clinics by Tiffany A. Ho, Katelyn M. Patterson, Shirish M. Gadgeel, Rachel M. Kenney, Michael P. Veve

Get full text

ACTIVITY OF THE PAN-HER TYROSINE KINASE (TK) INHIBITOR DACOMITINIB (PF-00299804) IN REFRACTORY NONADENOCARCINOMA (NON-A) NON-SMALL CELL LUNG CANCER (NSCLC) AND COMPARED WITH ERLOTI... by Blackhall, F, Gadgeel, S, Reckamp, K, Talbot, D, Barrios, C, Krzakowski, M, Liang, J, O'Connell, J

A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors by Nagasaka M, Abdallah N, Crosby M, Thummala N, Patel D, Wozniak AJ, Gadgeel S, Abrams J, Sukari A

Get full text

Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR. by Shirish M Gadgeel, Wei Chen, Michele L Cote, Aliccia Bollig-Fischer, Susan Land, Ann G Schwartz, Gerold Bepler

Get full text

Phase I dose escalation study of Linsitinib (OSI-906) and Erlotinib in patients with advanced solid tumors by Macaulay, V, Middleton, M, Eckhardt, S, Rudin, C, Juergens, R, Gedrich, R, Gogov, S, McCarthy, S, Poondru, S, Stephens, A, Gadgeel, S

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting by Shirish M. Gadgeel, Pragya Rai, Srinivas Annavarapu, Sartaj Alam, Jerome H. Goldschmidt, Howard (Jack) West, Melissa Santorelli, Renata Eiras Martins

Get full text

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Stud... by Gadgeel S, Shaw AT, Barlesi F, Crino L, Yang JCH, Dingemans AM, Kim DW, de Marinis F, Schulz M, Liu S, Gupta R, Smoljanovic V, Ou SHI

Get full text

Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189 by Shirish Gadgeel, MD, Jhanelle E. Gray, MD, Maria Teresa Rizzo, MD, Patrick Peterson, PhD, Jong Seok Kim, MD, Delvys Rodríguez-Abreu, MD, PhD

Get full text

Lung Cancer Screening Criteria and Cardiopulmonary Comorbidities by Chan Yeu Pu, MD, MS, Christine M. Lusk, MPH, Christine Neslund-Dudas, PhD, Shirish Gadgeel, MD, Ayman O. Soubani, MD, Ann G. Schwartz, MPH, PhD

Get full text

Clinical Outcome in Patients With Early-Stage Small Cell Lung Cancer Treated With Surgery or Radiation in the Absence of Prophylactic Cranial Irradiation: A Single-Center Retrospec... by Sondos Al Khatib, MD, Khalid Adil, MD, Lonni Schultz, MS, Shirish Gadgeel, MD, Andrew Popoff, MD, Munther Ajlouni, MD, Michael Simoff, MD, Benjamin Movsas, MD, Aharon Feldman, MD

Get full text

Brief Report: Prognostic Relevance of 3q Amplification in Squamous Cell Carcinoma of the Lung by Fawzi Abu Rous, MD, Pin Li, PhD, Shannon Carskadon, MS, Sunny RK. Singh, MD, Rebecca Chacko, MD, Hassan Abushukair, BS, Shirish Gadgeel, MD, Nallasivam Palanisamy, PhD

Get full text

A Phase II Study of the Multikinase Inhibitor Ponatinib in Patients With Advanced, RET-Rearranged NSCLC by Justin F. Gainor, MD, Shirish Gadgeel, M.B.B.S., Sai-Hong I. Ou, MD, PhD, Beow Yeap, ScD, Gregory A. Otterson, MD, Alice T. Shaw, MD, PhD

Get full text

Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatm... by Johannes Noé, PhD, Walter Bordogna, PhD, Venice Archer, MD, Vlatka Smoljanovic, MD, Magalie Hilton, MSc, Ryan Woodhouse, BSc, Simonetta Mocci, MD, PhD, Shirish M. Gadgeel, MD

Get full text

Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones by Matthew D Fountain, Matthew D Fountain, Lisa M Abernathy, Lisa M Abernathy, Fulvio Lonardo, Shoshana E Rothstein, Michael M Dominello, Wei Chen, Shirish M Gadgeel, Michael C Joiner, Gilda Gali Hillman

Get full text

Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients... by Natale, R, Blackhall, F, Kowalski, D, Ramlau, R, Bepler, G, Grossi, F, Lerchenmüller, C, Pinder-Schenck, M, Mezger, J, Danson, S, Gadgeel, S, Summers, Y, Callies, S, André, V, Das, M, Lahn, M, Talbot, D